Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 10 - 12 tags : Cancer save search
Galectin Therapeutics Receives FDA Approval to Proceed with Combination Immunotherapy Trial in Head and Neck Cancer
Published: 2022-10-12 (Crawled : 14:20) - biospace.com/
GALT | $3.29 -2.66% 120K
|
Health Technology
|
| O: 5.56%
H: 0.0%
C: -8.77%
fda immunotherapy trial approval therapeutics cancer
Propanc Biopharma’s CEO to Attend 43rd Meeting of the European Organization of Research & Treatment of Cancer (EORTC), Dec 15 - 17
Published: 2022-10-12 (Crawled : 14:00) - biospace.com/
PPCB | $0.0011 -41.86% 5.6M
|
Manufacturing
|
| O: 0.0%
H: 8.33%
C: 0.0%
treatment ceo research meeting cancer
Leap Therapeutics Announces First Patient Enrolled in Part C of Phase 2 DisTinGuish Study of DKN-01 in Combination with Tislelizumab for the Treatment of Gastric or Gastroesophageal Junction Cancer
Published: 2022-10-12 (Crawled : 14:00) - biospace.com/
LPTX | $3.255 1.72% 130K
|
Health Technology
|
| O: 0.7%
H: 2.79%
C: 0.24%
BGNE | $143.32 3.12% 150K
|
Health Technology
|
| O: 2.77%
H: 20.74%
C: 17.3%
dkn-01 treatment therapeutics leap cancer study
Janux Therapeutics Announces First Patient Dosed with JANX007 in First-in-Human Phase 1 Clinical Trial in Patients with Prostate Cancer
Published: 2022-10-12 (Crawled : 14:00) - biospace.com/
JANX | $48.42 -2.73% 500K
|
Professional, Scientific, and T...
|
| O: -0.55%
H: 7.47%
C: 6.37%
janx007 trial therapeutics cancer prostate cancer phase 1
BriaCell Announces New Clinical Trial Site to Bring Novel Cancer Treatments to Advanced Breast Cancer Patients
Published: 2022-10-12 (Crawled : 13:20) - biospace.com/
BCTX | $2.2 15K
|
Professional, Scientific, and T...
|
| O: -0.17%
H: 7.06%
C: 5.88%
breast trial cancer
Mirati Therapeutics and Aadi Bioscience Partner to Evaluate the Combination of Adagrasib with Nab-sirolimus in Patients with Advanced Non-Small Cell Lung Cancer and Other Solid Tumors with a KRAS[G12C] Mutation
Published: 2022-10-12 (Crawled : 13:00) - biospace.com/
AADI | $1.795 -2.45% 92K
|
Manufacturing
|
| O: 3.7%
H: 0.0%
C: -7.64%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: 0.14%
H: 5.61%
C: 5.46%
lung therapeutics tumors bioscience cancer
Jaguar Animal Health Co-Sponsoring Closing Ceremony at Veterinary Cancer Society Annual Conference on October 15th to Drive Awareness of Jaguar's Take C.H.A.R.G.E. (Canine Health And ReGistry Exchange) Initiative
Published: 2022-10-12 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.166 -1.19% 31M
|
Health Technology
|
| O: -0.35%
H: 7.73%
C: 0.5%
veterinary conference health animal cancer
Merck and Moderna Announce Exercise of Option by Merck for Joint Development and Commercialization of Investigational Personalized Cancer Vaccine
Published: 2022-10-12 (Crawled : 12:00) - biospace.com/
MRK | $127.345 0.37% 4.6M
|
Health Technology
|
| O: 0.22%
H: 0.52%
C: -0.91%
MRNA | News S | $108.52 0.58% 2.6M
|
Health Technology
|
| O: 12.29%
H: 4.36%
C: -3.57%
vaccine commercialization cancer
Biodesix to Present Data at the CHEST 2022 Annual Meeting Demonstrating High Sensitivity of the Nodify XL2® Blood-Based Lung Nodule Test in Various Patient Populations, Including Individuals Participating in Lung Cancer Screening Programs
Published: 2022-10-12 (Crawled : 11:00) - biospace.com/
BDSX | $1.28 3.7K
|
Health Services
|
| O: 3.94%
H: 4.55%
C: -10.61%
xl2 lung test meeting cancer
Kronos Bio to Present Preclinical Data for KB-0742, an Oral CDK9 Inhibitor Targeting MYC-amplified Cancers, in Pediatric Cancer Models in Poster Presentation at EORTC-NCI-AACR 2022
Published: 2022-10-12 (Crawled : 09:00) - globenewswire.com
KRON | $0.9745 2.58% 750K
|
Health Technology
|
| O: -0.68%
H: 1.02%
C: -2.39%
kb-0742 preclinical presentation cancer
Kronos Bio to Present Preclinical Data for KB-0742, an Oral CDK9 Inhibitor Targeting MYC-amplified Cancers, in Pediatric Cancer Models in Poster Presentation at EORTC-NCI-AACR 2022 Kronos Bio, Inc., a ...
Published: 2022-10-12 (Crawled : 09:00) - biospace.com/
SGMO | News | $0.4989 -4.22% 880K
|
Health Technology
|
| O: -0.21%
H: 0.63%
C: 0.0%
NKTR | News | $1.385 -2.47% 700K
|
Health Technology
|
| O: -1.69%
H: 3.29%
C: 0.57%
KRON | $0.9745 2.58% 750K
|
Health Technology
|
| O: -0.68%
H: 1.02%
C: -2.39%
kb-0742 preclinical presentation cancer
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
CSSE 4 | $0.3831 151.54% 190M
|
Consumer Services
CZOO | $11.04 121.24% 11M
|
LICN | $0.9107 62.63% 14M
|
BOF | $1.87 59.83% 100M
|
AMST | $3.18 59.0% 67M
|
Technology Services
MTC | $3.31 47.77% 7.7M
|
Technology Services
MULN | News | $3.915 43.41% 12M
|
Information
WIMI | $1.04 43.37% 17M
|
Technology Services
SKIL 4 | $8.045 40.89% 230K
|
Information
RILY | $30.01 38.17% 11M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.